dbq33b4p7

A heterocyclic alkaloid.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

dbq33b4p7 is a tylophorine derivative with in vitro anti-SARS-CoV-2 activity (Yang et al., 2020).

Link	Tested on	Impact factor	Notes	Publication date
Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives Small molecule In vitro	Vero E6 cells	4.23	Manifested in vitro anti-SARS-CoV-2 activity in Vero E6 cells with EC50 of20 nM in a cytopathic effect assay and 31.9 nM in an immunofluorescence assay, with a selectivity index of 125 or 93.	Dec/14/2020